Ocaliva Lawsuit Lawyer in Nashville: A Step-by-Step Essential Guide to the FDA Recall Process [May, 2026]

• Lawsuit Status: Investigations are active, and Ocaliva lawsuits are in early stages; no large-scale public settlements or jury trials have been announced yet.

• Allegations: Ocaliva lawsuits allege Intercept Pharmaceuticals failed to adequately warn patients and doctors about the risks of Ocaliva and liver failure, other serious Ocaliva side effects and delayed in communicating safety risks, and marketed a defective drug that caused serious Injuries linked to Ocaliva use.

• Primary Injuries: Claims focus on patients who experienced sudden liver decline, cirrhosis progression, or required liver transplants after using Ocaliva.

• Highest Risk Data: In December 2024, the FDA reported that Ocaliva users faced a 377% higher risk of liver transplant or death compared to those on a placebo.

Ocaliva Lawsuit Allegations and Timeline:

• 2017: FDA issues first safety alert regarding Ocaliva and liver failure due to improper dosing.

• 2018: A “Black Box Warning” (the most serious type) was added for incorrect dosing.

• 2021: The FDA restricted Ocaliva use, stating it should not be used in patients with advanced cirrhosis, following reports of severe Ocaliva and liver failure.

• 2024: Data reveals serious injuries in patients without pre-existing cirrhosis, with a 377% higher risk of death or transplant.

• Nov 14, 2025: Final withdrawal of Ocaliva from U.S. pharmacy shelves

What Is a Recall?

A recall is an action taken to correct or remove from the market a product regulated by the FDA that does not comply with U.S. laws and regulations. Companies may initiate recalls voluntarily, or sometimes the FDA requests them. Recalls are crucial for safeguarding public health—they help prevent injuries, illnesses, and even deaths caused by unsafe products. In fact, from 2014 to 2024, more than 83,000 FDA-regulated products were recalled.

Most recalls mean pulling non-compliant products from shelves and distribution. However, some issues can be fixed without removing the product entirely. For instance:

• Large equipment, like MRI machines, might be too big to remove from a facility; instead, repairs or corrections can be made on-site.

• Food products with missing allergen information—such as wheat, milk, or peanuts—can have updated labels affixed before they reach store shelves.

In short, recalls are essential tools for keeping potentially harmful products out of consumers’ hands while sometimes allowing for practical solutions when removal isn’t feasible.The untimate objective product recall should be to remedy as many hazardous products and drugs from the total distribution cycle and, most notably, from consumers as fast, cost efficient,and in a cost-effective manner.

Why Are Products Recalled?

Products may be recalled for a variety of reasons, including:

• Reports of unexpected adverse events or reactions.
• Contamination with harmful microorganisms, such as Salmonella or E. coli.
• Discovery of foreign objects like metal fragments, broken glass, or plastic pieces in the product.
• Manufacturing defects compromising safety
• Inaccurate results from products meant for testing or diagnosis, even when used as instructed.
• Products labeled as sterile that are actually non-sterile.
• Missing information on major allergens or undeclared key ingredients on the label.

In short, recalls happen whenever a product poses a risk to users’ health or safety—whether due to contamination, labeling errors, manufacturing flaws, or misleading results.

If you suffered Ocaliva and liver failure or suffered injuries linked to Ocaliva use, or lost a loved one to Ocaliva liver injuries, contact Nashville Ocaliva lawsuit lawyer Timothy L. Miles today who can tell you if you qualify for an Ocaliva lawsuit and possibly may be entitled to significant compensation.

How the Public Learns about Recalls?

• When a company takes steps to correct or remove a medical device, the FDA shares details about the action in its Medical Device Recall Database. This database is regularly updated—first when the recall is officially classified, and again once the recall has been resolved.

• Beyond database updates, the FDA may also publish company press releases or public notices regarding recalls, market withdrawals, or safety alerts—especially when there’s a significant risk to consumers or users.

• Once a recall receives its classification, the FDA includes it in its weekly Enforcement Report. For recalls considered most serious (Class I) and some Class II and III cases, additional consumer information is posted to ensure patients understand the potential health risks involved.

• In short, the FDA takes multiple steps to keep both professionals and the public informed about medical device recalls—so everyone stays aware of important safety concerns as they arise.

Who Initiates an Ocaliva Recall: FDA vs Manufacturer

A common misconception is that the FDA “issues” most recalls. In practice, most recalls are voluntary actions initiated by the manufacturer after internal detection, customer complaints, post market signals, supplier findings, or verification failures. The FDA’s primary involvement in a recall is to oversee a company’s recall strategy, assess the adequacy of the company’s action, and classify the recall.

What is a Recall Letter?

When a company initiates a recall, it is their responsibility to quickly notify all direct accounts affected by the recalled product. The way this message is delivered—the format, content, and level of detail—should match the seriousness of the hazard involved and align with the established recall strategy.

The main goals of an effective recall communication are to:

• Clearly state that the specific product is being recalled.
• Instruct recipients to immediately stop distributing or using any remaining product.
• Where necessary, advise direct accounts to inform their own customers who may have received the affected product.
• Provide clear instructions on what steps to take with the recalled item (such as returning or disposing of it).

Best practices for issuing a recall notification include:

• Sending telegrams, mailgrams, or first-class letters that are clearly labeled—preferably in bold red type on both the letter and envelope—with phrases like “medical device recall” (or “correction” as appropriate).
• Marking both the letter and envelope as “urgent” for Class I and Class II recalls, and for Class III recalls when warranted by the situation.
• While telephone calls or personal contacts can be used for speed or clarity, these communications should always be confirmed in writing (using one of the methods above) and properly documented for records.

This approach ensures that everyone in the supply chain receives timely, unmistakable notice about the recall, understands its urgency, and knows exactly how to respond to protect patient safety.

The Typical FDA Recall Lifecycle (How It Works End to End)

1. Problem Identification and Assessment

Class II (Moderate Risk):

A situation that may cause temporary or medically reversible adverse health consequences, where the probability of serious consequences is remote (e.g., defective medical device).

Characteristics of class 3 recalls:

• Lowest priority, very minimal risk to health
• Normally these are limited to the wholesale or retail level
• Usually does not warrant public notification
• Normally involve a technical violation of a FDA regulation rather than causing actual harm as in the case Ocaliva liver damage